Summary. Aminoglycoside-resistant variants of Pseudornonas aeruginosa strain P A 0 1 were readily selected by culturing the organism in medium containing increasing concentrations of gentamicin, tobramycin or amikacin until the strains were growing in a concentration of drug 128-fold greater than the minimal inhibitory concentration for the sensitive parent strain. These resistant strains exhibited characteristics previously associated with the impermeability type of resistance mechanism, i.e., they grew more slowly than the parent strain, the resistance was unstable in the absence of the antibiotic, and adaptation to one of the antibiotics conferred crossresistance to other aminoglycosides. The adapted strains grew, with minimal morphological alterations, in concentrations of the various aminoglycosides that normally produced cell envelope damage, misshapen and filamentous cell formation, and cell lysis in the sensitive strain. Neither protein H1 nor phospholipid alterations appear to play a significant role in adaptive resistance to aminoglycoside antibiotics in this model system. The acquisition of adaptive resistance to the aminoglycoside antibiotics did not confer resistance to polymyxin B, another cationic antibiotic which is thought to share binding sites within the outer membrane with the aminoglycosides.
Introduction
lipid alterations, including a decrease in the Resistance to the cationic polymyxin and aminoglycoside antibiotics remains an incompletely understood phenomenon. When grown in the presence of one of these antibiotics, a population of gram-negative enteric rods or pseudomonads may exhibit increased resistance to the antibiotic through an unstable "impermeability mechanism". This resistance is readily lost when the strain is grown in the absence of the antibiotic. We have previously studied adaptive resistance to polymyxin B in a model system with Pseudornonas aeruginosa (Gilleland and Murray, 1976) . The adaptation to increased polymyxin resistance involves both ultrastructural (Gilleland and Murray, 1976) and various chemical (Gilleland and Lyle, 1979; Conrad and Gilleland, 1981 ; Champlin et al., 1983) alterations of the outer membrane (OM) resulting in the prevention of polymyxin reaching the still sensitive cytoplasmic membrane (Gilleland and Farley, 1982) . The chemical alterations comprised various phospholipid content in the readily extractable lipid (REL) with a reduction in phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) content (Conrad and Gilleland, 198 I) , accompanied by the appearance of a large amount of free fatty acids (Champlin et al., 1983) . We (Conrad and Gilleland, 1981 ; Champlin et al., 1983; Gilleland et al., 1984; Gilleland, 1988) and others (Kubesch et al., 1987) have proposed that changes in both the lipopolysaccharide (LPS) and the phospholipid composition of the OM might reduce the number of binding sites for polymyxin and render the OM more resistant to polymyxin. Kubesch et al. (1987) identified that PG, the major anionic phospholipid in the cell envelope, plays a critical role for the action of polymyxin on bacterial membranes.
The aminoglycoside antibiotics are a much more clinically important group of cationic antibiotics than are the polymyxins. It has been proposed (Hancock, 1981 (Hancock, , 1986 Abdel-Sayed et al., 1982; Eagon, 1984; Taber et al., 1987) that the aminoglycoside antibiotics penetrate through the OM via a self-promoted pathway mediated by binding to cation-binding sites within the OM. Both the polymyxins and the aminoglycosides are thought to bind to the same sites within the OM, and Hancock and co-workers (Nicas and Hancock, 1980, 1983; Hancock, 1981; Hancock et al., 1981) have proposed that induction of OM-protein H1 in P. aeruginosa confers resistance to both the polymyxins and the aminoglycosides by protecting the binding site on LPS from attack. However, the role of the H1 protein in conferring resistance to these antibiotics has been disputed (Gilleland and Conrad, 1982; Said et al., 1987) . Various investigators (Pechey and James, 1974; Dimitracopoulos et al., 1979; Al-Asadi et al., 1981 ; Bayer et al., 1987) have reported the isolation of aminoglycoside-resistant strains that exhibit the impermeability mechanism of resistance. This mechanism of resistance to the aminoglycoside antibiotics has been associated with alterations in LPS (Bryan et al., 1984; Galbraith et al., 1984; Clark et al., 1986) . In this study we examined strains of P. aeruginosa made adaptively resistant to gentamicin, tobramycin and amikacin for the presence of alterations in their content of OM proteins and cell-envelope phospholipids. In particular, we examined whether the PG content of these aminoglycoside-resistant strains was reduced in a similar manner to the polymyxinresistant strains.
Materials and methods

Bacterial strains
The aminoglycoside-resistant strains were all selected from the PAOl parent strain of P. ueruginosu, which was susceptible to MICs of gentamicin 1 mg/L, tobramycin 0.5 mg/L, and amikacin 4 mg/L. A resistant variant to each aminoglycoside was selected by stepwise growth of strain PAOl in the presence of increasing concentrations of antibiotic until the strain was growing in the presence of an antibiotic concentration 128-fold greater than the MIC for the parent PAOl strain. Thus, the gentamicinresistant strain (PAOl-Gen') was obtained by adding 3 ml of a logarithmic-phase culture of strain PAOl in basal medium (BM) after adjusting the absorbance at 660 nm (A660) to 0.3, corresponding to a cell count of (5-7.5) x lo8 cfulml, to 50 ml of BM containing gentamicin 1 mg/L in a 125-ml Erlenmeyer flask. After aerobic incubation at 30°C for 36 h, this culture was diluted with BM to give an A660 of 0.3, and 3 ml was added to 50 ml of BM containing gentamicin 2mg/L, followed by incubation of the flask at 30°C with shaking for 24 h. This stepwise transfer into media containing two-fold increases in the concentration of gentamicin was continued until the organism was growing in a gentamicin concentration of 128 mg/L. A loopful of culture from this flask was streakedon basal medium agar plates containing gentamicin 100 mg/L, and an isolated colony was picked as the PAOl-Gen' strain. Similar adaptation procedures were used to obtain a tobramycin-resistant (PAOl-Tob') and an amikacin-resistant (PAOl-Ami') strain able to grow in the presence of tobramycin 64mg/L and amikacin 512 mg/L respectively.
Growth media
The PAOl strain was grown in a basal medium (BM) previously described as "basal medium 2" (Gilleland et a!., 1974) . This medium contained the following ingredients adjusted to pH 7.0: 0.03 M glucose, 0.04 M K2HP04, 0.022 M KH2P04, 0.007 M (NH4)*S04, and 0.0005 M MgS04. The aminoglycoside-resistant strains were grown in BM containing gentamicin 100 mg/L for the PAOlGen' strain, tobramycin 50 mg/L for the PAOl-Tob' strain, and amikacin 500 mg/L for the PAOl-Ami' strain.
Cells for experiments were routinely grown at 30°C with aeration either in 125-ml Erlenmeyer flasks containing 50 ml of the appropriate medium or in 4-L Erlenmeyer flasks containing 2 L of medium.
Determination of growth characteristics
The growth characteristics for the PAOl strain and each of the three aminoglycoside-resistant strains were determined as follows. A 300-ml side arm Erlenmeyer flask containing 20ml of BM plus the appropriate concentration of antibiotic was seeded from a logarithmic-phase starter culture to give an initial A660 reading of 0.05. The flasks were incubated at 30°C in a shaking water bath, and A660 readings were taken at 1-2 h intervals for 22 h.
Reversion of the aminoglycoside-resistant strains
The ability ofthe PAOl-Gen', PAOl-Tob', and PAO1-Ami' strains to revert to antibiotic susceptibility was assessed as follows. An inoculum of 0.5 ml from a logarithmic culture growing in BM plus the appropriate antibiotic was used to inoculate a flask containing 50 ml of BM without antibiotic for each strain. After incubation for 24 h at 30°C with shaking, 0.5 ml was transferred to a second flask containing 50 ml of BM without antibiotic and again incubated for 24 h. These cells were used as inocula for MIC determinations (see below) and for cultures for cell envelope preparation. Data regarding reverted strains were obtained after growth of the strains for three successive transfers in antibiotic-free BM.
Determination of minimal inhibitory concentrations of various antibiotics
The MICs of various antibiotics were determined for the parent PAOl strain, the three aminoglycosideresistant strains, and the three reverted strains as described by Gilleland and Farley (1982 
Electronmicroscopy of thin-sectioned preparations
All strains were prepared and fixed with glutaraldehyde and OsO4, with poststaining of sections with uranyl acetate and lead citrate as described by Gilleland and Farley (1 982) .
Analysis of cell-envelope proteins
Cell envelopes were prepared from the PAOl strain, the three aminoglycoside-resistant strains, and the reverted strains according to the procedure of Stinnett et al. (1973) . Proteins were extracted from these cell envelopes and analysed by slab sodium dodecylsulphatepolyacrylamide gel electrophoresis as described by Gilleland and Lyle (1 979).
Lipid analysis
The PAOl strain grown in BM and the three aminoglycoside-resistant strains grown in BM containing the appropriate antibiotic were used for lipid analysis. (1957) . The cellular dry weight percentage of RELs was measured gravimetrically (Conrad and Gilleland, 1981) . The phosphate content of REL fractions was measured by the method of Ames and Dubin (1960) . Lipids in the REL fractions were resolved by thin-layer chromatography on Adsorbosil-Plus 1 silica gel plates (Alltech Associates, Inc., Deerfield, IL). Chromatograms were developed to a distance of 10 cm in chloroform : methanol : acetic acid :water (85 : 15 : 10: 3.5) (Hanna et al., 1984) , air dried, and developed to a distance of 14 cm in hexane : diethyl ether (4: 1). Separated lipids were visualised by spraying with potassium dichromate-saturated 50% H2S0, and charring at 150°C for 30 min. RELs were tentatively identified by cochromatography with authentic reference lipids (Sigma Chemical Co., St Louis, MO) which included diphosphatidylglycerol (DPG), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), palmitic acid, and oleic acid. The ratios of individual lipids were determined by scanning densitometry as previously described (Conrad and Gilleland, 1981) .
Statistical analysis
The statistical significance of the results of the lipid analysis was determined by Student's t test on the means, with (two-tailed) p-values of 0-05 and lower considered significant .
Results
Characteristics of the aminoglycoside-resistant strains
Strains resistant to each of the three aminoglycoside antibiotics were readily obtained but they grew more slowly than did the parent strain (PAO1) and attained a lower cell density in cultures. In the absence of antibiotic, the sensitive PAOl strain grew in BM with a doubling time of 2.6 h to reach a final A660 reading of 1.2 within an incubation period of 16 h. The PAOl-Gen' strain grew in BM plus gentamicin 100 mg/L with a doubling time of 3 h to reach a final A660 reading of 1.0 within 20 h. The PAOl-Tob' strain grew in BM containing tobramycin 50 mg/L with a doubling time of 3.9 h to reach a final A660 reading of 0.75 within 18 h. The PAOl-Ami' strain grew in BM plus amikacin 500 mg/L with a doubling time of 5.3 h to reach a final A660 reading of 0.68 within 22 h.
Adaptive resistance from growth in the presence of one of the aminoglycoside antibiotics conferred cross-resistance to the other three aminoglycosides tested (table I). The adaptive resistance was unstable; growth of the resistant strains for three transfers in BM without antibiotic resulted in all three strains reverting to antibiotic susceptibility (table I) .
Electronmicroscopy of thin-sectioned preparations
The unadapted PAOl strain could not survive and grow, even with prolonged incubation, in BM containing gentamicin 100 mg/L, tobramycin 50 mg/L, or amikacin 500 mg/L. Exposure of PA01 cells to gentamicin 100 mg/L resulted in a progression of cellular damage as shown in fig. 1 . After exposure to gentamicin for 30 min ( fig. 1 A) , numerous small blebs of the OM were seen, with an occasional larger ballooning out of the membrane. After exposure for 1 h ( fig. IB) , more filamentous cells were found, and the cells also became more misshapen. The cell population became even more misshapen and filamentous after exposure for 2 h ( fig. 1 C) , and lysis of cells began to occur. By 4h, most of the cells were in various stages of lysis ( fig. 1D ). Exposure to tobramycin 50mg/L had a similar effect on the PAOl cells; blebbing of the OM and misshapen cells were prominent findings ( fig. 2A ). Lesions and infoldings of the cytoplasmic membrane were more extensive in cells exposed to tobramycin ( fig. 2C ) than in those exposed to gentamicin. Extensive cell lysis occurred in tobramycin-exposed cells by 4 h, with L. B. GILLELAND ET AL. separation of the OM from the cytoplasmic membrane ( fig. 2D ) frequently preceding lysis. Amikacin produced effects in the PAOl cells ( fig. 2B ) similar to those produced by the other two aminoglycosides. However, the cells were not as misshapen nor was the cytoplasm as darkly staining within the first hour as with gentamicin or tobramycin. The resistant strains were capable of survival and growth in the presence of the concentrations of aminoglycoside antibiotics which produced extensive cell damage and lysis in the PAOl strain. These strains did not show the ballooning and separation of the OM layer, the formation of grossly misshapen and filamentous cells, the cytoplasmic membrane infoldings, and the cell lysis produced in the PAOl strain by these concentrations of antibiotics. These resistant strains appeared remarkably healthy. However, in comparison to the PAOl strain grown in BM, growth in the presence of the antibiotic did result in slightly misshapen cells.
Analysis of OM proteins
In all the resistant strains there was a reduction in a number of outer membrane protein bands in comparison to the sensitive PAOl strain and the reverted strains ( fig. 3) . All three resistant strains demonstrated a reduced content of several of the bands in the 73-69-Kda range. Most obviously associated with loss and regain in all three strains was the 69-Kda band, which was reduced in all three strains and regained to wild-type concentrations in all three reverted strains. Protein F (porin, 36 Kda) was reduced in all three strains, as was protein Hl(21 Kda). No band was increased in the resistant strains relative to the PAOl and reverted strains.
Lipid analysis
Separation of REL fraction lipids by thin-layer chromatography revealed no apparent alteration of lipid composition in any of the aminoglycosideresistant strains compared with the parental PAOl strain. Quantitation of individual lipids by densitometry (table 11) confirmed that there were no consistently significant differences between the content of the various lipids in the PAOl strain and in the three resistant strains. The only statistically significant differences between the PAOl strain and the resistant strains were an increase in free fatty acids in the PAOl-Ami' strain and an increase in DPG in the PAOl-Tob' strain (table 11) . Although the PG content was slightly reduced in all three resistant strains (reduction of 7.4% in PAOl-Gen', 12% in PAOl-Tob', and 10.7% in PAOl-Ami') compared to the PAOl strain, the magnitude of the reduction did not approach the 74-90% reduction in PG content previously reported (Conrad and Gilleland, 1981 ; Champlin et al., 1983) for the polymyxin-resistant P . aeruginosa strains. Neither the cell percentage of REL nor the phospholipid proportion of the REL (as measured by determining pmol of phosphorus per mg of REL) differed significantly between the PAOl and the resistant strains (table 11) . Thus, the adaptation to aminoglycoside resistance did not result in any significant alteration in lipid content in the REL.
Discussion
In our in-vitro model of resistance to aminoglycoside antibiotics, resistant strains were readily obtained for each of the three antibiotics used. All three resistant strains exhibited characteristics associated with the impermeability mechanism of resistance. These characteristics included slower growth than the parent strain (Gilleland and Murray, 1976 ; Eagon, 1984) and cross-resistance to all four aminoglycosides tested (Pechey and James, 1974; Al-Asadi et al., 1981 ; Shannon and Phillips, 1982) . This resistance was unstable and strains readily reverted to susceptibility during several transfers in the absence of antibiotic (Pechey and James, 1974; Gilleland and Murray, 1976; Dimitracopoulos et al., 1979; Bayer et al., 1987) . Furthermore, we were unable to detect aminoglycosideinactivating enzymes in any of the three resistant strains by techniques that did allow demonstration of such an enzyme from a positive control strain (data not shown). Therefore, we conclude that our resistant strains were resistant by an impermeability mechanism. The precise role played by the impermeability antibiotic in the patient would lose the resistance type of resistance to aminoglycoside antibiotics in upon routine culturing for isolation in the clinical clinical medicine remains undetermined. Since this laboratory and would appear to be susceptible to type of resistance is generally unstable in the the antibiotic upon routine testing of antibiotic absence of the antibiotic, strains possessing im-susceptibilities in the clinical laboratory (Gerber et permeable-type resistance in the presence of the al., 1982) . Emergence of such aminoglycoside- t Seven to eight determinations were used for each value.
$ Three determinations were used for each value.
0 Eight to ten determinations were used for each value.
* Value is statistically significantly different from the equivalent value for the PAOl strain as determined by Student's t test on the means, employing the two-tailed t table.
resistant strains has been shown to occur not only in uitro but also in animal models Bayer et al., 1987) and in human patients (Bryan et al., 1976; Mawer and Greenwood, 1977; Bryan et al., 1984; Olson et al., 1985) . The emergence of resistance occurs more frequently with P. aeruginosa than with the Enterobacteriaceae Nilsson et al., 1987) and is thought to play a role in the difficulty encountered in treating infections caused by P. aeruginosa with aminoglycoside therapy (Olson et al., 1985) . Clinical strains displaying the impermeability type of resistance have low-level aminoglycoside resistance, which some authors attribute to the antibiotic selection of resistant subpopulations already existing in the generally susceptible population. However, it appears that a pre-existing resistant subpopulation is not necessary for the emergence of adaptive resistance, because newly resistant subpopulations also appear (Olson et al., 1985) . Indeed, in-vitro models of resistance development to high-level resistance, after several steps, show strains growing in antibiotic concentrations which would normally kill a population of the original parent strain. We believe that the emergence of more resistant subpopulations, which are not found in the initial cell population, plays a role in in-vitro models and in-vivo clinical situations. In this study the three resistant strains were grown routinely in the presence of aminoglycosides in concentrations corresponding to 100 x MIC for the parent PAOl strain, with only quite minor aberrations in cell morphology. These minor ultrastructural abnormalities in cell shape may indicate that exclusion of the antibiotic by the impermeability mechanism is not absolute but that only small quantities are able to penetrate. However, the resistant cells are protected against extensive ultrastructural alterations (misshapen and filamentous cells, figs. 1,2A, and 2B) which these antibiotic concentrations produce in the PAOl strain. Others (Nishino and Nakazawa, 1975; Martin and Beveridge, 1986 ) have reported that aminoglycoside antibiotics cause breaks or holes in the cell envelope layers of susceptible cells, as well as causing blebbing or outpouching of the OM (Iida and Koike, 1974; Nishino and Nakazawa, 1975; Martin and Beveridge, 1986) . We found similar effects in the PAOl strain treated with each of the aminoglycoside antibiotics. In addition to the OM and cytoplasmic membrane alterations noted, the antibiotics all produced alterations in cell morphology, with extensive cell lysis occurring after exposure for 2-4 h. Marked morphological changes with a loss of cell shape and the occurrence of rounded cells leading to lytic death of P . aeruginosa upon exposure to aminoglycoside antibiotics was described previously by Nishino and Nakazawa (1975) and by Lorian and Atkinson (1986) . We believe these morphological changes and cell lysis result from indirect effects on cell metabolic processes consequent upon inhibition of protein synthesis by the binding of the aminoglycoside to the 30s ribosomal subunit. The resistant strains described here would be protected from these effects by exclusion of the antibiotic from entry into the cytoplasm in sufficient quantity to disrupt cell metabolism .
In this study we examined the role played by two different cell-envelope components in the adaptive impermeability type of resistance to aminoglycoside antibiotics. An increase in OM protein H1 has been proposed (Nicas and Hancock, 1980, 1983; Hancock, 1981; Hancock et al., 1981) to mediate resistance to aminoglycosides, polymyxin B, and EDTA. However, since no increase in OM protein H1 was evident in any of the three resistant strains ( fig. 3 ), we could find no evidence that this protein plays any role in adaptive resistance to aminoglycosides in our model system. Several of the other OM proteins were reduced in all three adapted strains. However, since the aminoglycoside antibiotics are believed not to use OM porins for entry but to cross the OM by a self-promoted pathway involving binding to cationic binding sites within the OM (Abdel-Sayed et al., 1982; Hancock, 1986) , the possible significance of the reduced content of these OM proteins is uncertain. However, the reduction in several bands in the 73-69-Kda range is noteworthy since Morris and Brown (1988) recently reported that subinhibitory concentrations of the aminoglycosides inhibit the production of iron-chelating siderophores. Certain of these high molecular weight OM proteins may be ironregulated proteins that are reduced in the adapted strains. The second cell envelope component we examined for a possible role in adaptive aminoglycoside resistance was the composition of the REL fraction. Alterations in the phospholipid composition, particularly the loss of PG (Kubesch et al., 1987) , have been reported to be associated with adaptive resistance to another cationic antibiotic polymyxin B (Conrad and Gilleland, 1981 ; Champlin et al., 1982) . However, no consistent alteration in REL lipid content could be demonstrated in the three aminoglycoside-resistant strains (table II) , and we conclude that lipid alterations such as those reported for adaptive resistance to polymyxin B play no significant role in this resistance to the aminoglycosides. LPS alterations have been reported in strains exhibiting the impermeability type of resistance to aminoglycoside antibiotics in in-vitro models (Dimitracopoulos et al., 1979; Galbraith et al., 1984) and clinical isolates (Bryan et al., 1984; Clarke et al., 1986) . Alterations in LPS thus remain the most likely basis for adaptive resistance to the aminoglycosides.
It has been proposed (Brown, 1975; Hancock, 1981 ; Nicas and Hancock, 1980, 1983) that EDTA and the cationic aminoglycoside and polymyxin antibiotics all act at cationic binding sites on the LPS so that various conditions (growth in Mg2+-deficient medium, increase in OM protein H 1, etc.) confer resistance to all three agents. This implies that these agents share common binding require- 
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: 250-255. ments within the OM of P. aeruginosa. However, since resistance to polymyxin B (MIC raised from 6 mg/L for the PA01 strain to 5000 mg/L for isolate A) results in only low-level (2-fold increase in MIC) resistance to aminoglycoside antibiotics (Gilleland and Farley, 1982) and an 128-fold increase in MIC for aminoglycoside antibiotics results in no significant increase in resistance to polymyxin B (this study), we conclude that these two groups of cationic antibiotics must have, within the OM, certain binding requirements that are unique to each antibiotic group. The observation that lipid alterations appear to play an important role in resistance to polymyxin B but appear to play no significant role in adaptive resistance to aminoglycosides is consistent with this suggestion.
